MEGACE 160 MG
MEGESTROL ACETATE : 160 MG · DIN 00731323 · BRISTOL-MYERS SQUIBB CANADA
Health Canada status: CANCELLED POST MARKET
What is MEGACE?
MEGACE 160 MG contains MEGESTROL ACETATE : 160 MG. It is listed in the Health Canada Drug Product Database under DIN 00731323, held by BRISTOL-MYERS SQUIBB CANADA, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 09-Mar-2009. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00731323 |
|---|---|
| Brand name | MEGACE |
| Generic / active ingredient | MEGESTROL ACETATE : 160 MG |
| Manufacturer | BRISTOL-MYERS SQUIBB CANADA |
| Strength | 160 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | L02AB01 MEGESTROL |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 09-Mar-2009 |
Is MEGESTROL in shortage in Canada?
A Canadian shortage report is on file for this molecule: Active — reported by AA PHARMA INC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code L02AB01 MEGESTROL. 2 of 13 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| MEGESTROL | 160 MG | TABLET | AA PHARMA INC | MARKETED | DIN 02195925 |
| MEGESTROL | 40 MG | TABLET | AA PHARMA INC | MARKETED | DIN 02195917 |
| APO-MEGESTROL | 160 MG | TABLET | APOTEX INC | APPROVED | DIN 02405512 |
| APO-MEGESTROL | 40 MG | TABLET | APOTEX INC | APPROVED | DIN 02405504 |
| LINMEGESTROL - TAB 160MG | 160 MG | TABLET | LINSON PHARMA CO. | CANCELLED POST MARKET | DIN 02176106 |
| LINMEGESTROL - TAB 40MG | 40 MG | TABLET | LINSON PHARMA CO. | CANCELLED POST MARKET | DIN 02176092 |
| MEGACE | 40 MG | TABLET | BRISTOL-MYERS SQUIBB CANADA | CANCELLED POST MARKET | DIN 00386391 |
| MEGACE OS | 40 MG | SUSPENSION | BRISTOL-MYERS SQUIBB CANADA | CANCELLED POST MARKET | DIN 02168979 |
| MEGESTROL | 160 MG | TABLET | APOTEX INC | APPROVED | DIN 02185423 |
| MEGESTROL | 40 MG | TABLET | APOTEX INC | APPROVED | DIN 02185415 |
Who else supplies MEGESTROL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. MEGESTROL appears in 13 registered pack listings across 7 markets, published on 5 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.